| Chitosan and chitosan derivatives in drug delivery and tissue engineering R Riva, H Ragelle, A Des Rieux, N Duhem, C Jérôme, V Préat Chitosan for biomaterials II, 19-44, 2011 | 497 | 2011 |
| Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures H Ragelle, F Danhier, V Préat, R Langer, DG Anderson Expert opinion on drug delivery 14 (7), 851-864, 2017 | 422 | 2017 |
| Chitosan-based siRNA delivery systems H Ragelle, G Vandermeulen, V Préat Journal of Controlled Release 172 (1), 207-218, 2013 | 299 | 2013 |
| Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency H Ragelle, R Riva, G Vandermeulen, B Naeye, V Pourcelle, CS Le Duff, ... Journal of Controlled Release 176, 54-63, 2014 | 226 | 2014 |
| Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice H Ragelle, S Crauste-Manciet, J Seguin, D Brossard, D Scherman, ... International journal of pharmaceutics 427 (2), 452-459, 2012 | 221 | 2012 |
| Comprehensive proteomic characterization of stem cell-derived extracellular matrices H Ragelle, A Naba, BL Larson, F Zhou, M Prijić, CA Whittaker, ... Biomaterials 128, 147-159, 2017 | 172 | 2017 |
| Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and … C Corbet, H Ragelle, V Pourcelle, K Vanvarenberg, J Marchand-Brynaert, ... Journal of Controlled Release 223, 53-63, 2016 | 105 | 2016 |
| Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan–poly (ethylene imine) hybrid nanoparticles: A mechanistic insight H Ragelle, S Colombo, V Pourcelle, K Vanvarenberg, G Vandermeulen, ... Journal of Controlled Release 211, 1-9, 2015 | 68 | 2015 |
| Surface tension-assisted additive manufacturing H Ragelle, MW Tibbitt, SY Wu, MA Castillo, GZ Cheng, SP Gangadharan, ... Nature communications 9 (1), 1184, 2018 | 65 | 2018 |
| Additive manufacturing in drug delivery: Innovative drug product design and opportunities for industrial application H Ragelle, S Rahimian, EA Guzzi, PD Westenskow, MW Tibbitt, ... Advanced Drug Delivery Reviews 178, 113990, 2021 | 58 | 2021 |
| Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells F Roudnicky, JD Zhang, BK Kim, NJ Pandya, Y Lan, L Sach-Peltason, ... Proceedings of the National Academy of Sciences 117 (33), 19854-19865, 2020 | 53 | 2020 |
| Organ-on-a-chip technologies for advanced blood–retinal barrier models H Ragelle, A Goncalves, S Kustermann, DA Antonetti, A Jayagopal Journal of ocular pharmacology and therapeutics 36 (1), 30-41, 2020 | 47 | 2020 |
| Human retinal microvasculature‐on‐a‐chip for drug discovery H Ragelle, K Dernick, S Khemais, C Keppler, L Cousin, Y Farouz, ... Advanced healthcare materials 9 (21), 2001531, 2020 | 37 | 2020 |
| Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge S Colombo, X Zeng, H Ragelle, C Foged Expert opinion on drug delivery 11 (9), 1481-1495, 2014 | 34 | 2014 |
| Chitosan nanoparticles for SiRNA delivery in vitro H Ragelle, K Vanvarenberg, G Vandermeulen, V Préat SiRNA delivery methods: Methods and Protocols, 143-150, 2016 | 32 | 2016 |
| Chitosan for biomaterials II R Riva, H Ragelle, A des Rieux, N Duhem, C Jérôme, V Préat Springer, 2011 | 32 | 2011 |
| Microphysiological neurovascular barriers to model the inner retinal microvasculature TL Maurissen, G Pavlou, C Bichsel, R Villaseñor, RD Kamm, H Ragelle Journal of Personalized Medicine 12 (2), 148, 2022 | 13 | 2022 |
| Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip TL Maurissen, AJ Spielmann, G Schellenberg, M Bickle, JR Vieira, SY Lai, ... Nature Communications 15 (1), 1372, 2024 | 8 | 2024 |
| Retinal Microvasculature-on-a-Chip for Modeling VEGF-Induced Permeability H Ragelle, K Dernick, PD Westenskow, S Kustermann VEGF Signaling: Methods and Protocols, 239-257, 2022 | 1 | 2022 |
| Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells (vol 117, pg 19854, 2020) F Roudnicky, JD Zhang, BK Kim, NJ Pandya, Y Lan, L Sach-Peltason, ... PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF …, 2020 | 1 | 2020 |
